Pancreatic Neoplasms

"Pancreatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).

Descriptor ID	D010190
MeSH Number(s)	C04.588.274.761 C04.588.322.475 C06.301.761 C06.689.667 C19.344.421
Concept/Terms	Pancreatic Neoplasms Pancreatic Neoplasms Neoplasm, Pancreatic Pancreatic Neoplasm Pancreas Neoplasms Neoplasm, Pancreas Neoplasms, Pancreas Pancreas Neoplasm Neoplasms, Pancreatic Cancer of Pancreas Cancer of Pancreas Pancreas Cancers Pancreas Cancer Cancer, Pancreas Cancers, Pancreas Pancreatic Cancer Cancer, Pancreatic Cancers, Pancreatic Pancreatic Cancers Cancer of the Pancreas

Below are MeSH descriptors whose meaning is more general than "Pancreatic Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Digestive System Neoplasms [C04.588.274]
Pancreatic Neoplasms [C04.588.274.761]
Endocrine Gland Neoplasms [C04.588.322]
Pancreatic Neoplasms [C04.588.322.475]
Digestive System Diseases [C06]
Digestive System Neoplasms [C06.301]
Pancreatic Neoplasms [C06.301.761]
Pancreatic Diseases [C06.689]
Pancreatic Neoplasms [C06.689.667]
Endocrine System Diseases [C19]
Endocrine Gland Neoplasms [C19.344]
Pancreatic Neoplasms [C19.344.421]

Below are MeSH descriptors whose meaning is more specific than "Pancreatic Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pancreatic Neoplasms" by people in this website by year, and whether "Pancreatic Neoplasms" was a major or minor topic of these publications.

Bar chart showing 20 publications over 13 distinct years, with a maximum of 3 publications in 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2003	1	0	1
2004	1	0	1
2007	2	0	2
2008	0	1	1
2012	2	0	2
2013	1	0	1
2015	2	0	2
2016	1	0	1
2017	2	0	2
2019	2	0	2
2020	1	0	1
2023	3	0	3
2024	1	0	1

Below are the most recent publications written about "Pancreatic Neoplasms" by people in Profiles.

Murthy D, Attri KS, Shukla SK, Thakur R, Chaika NV, He C, Wang D, Jha K, Dasgupta A, King RJ, Mulder SE, Souchek J, Gebregiworgis T, Rai V, Patel R, Hu T, Rana S, Kollala SS, Pacheco C, Grandgenett PM, Yu F, Kumar V, Lazenby AJ, Black AR, Ulhannan S, Jain A, Edil BH, Klinkebiel DL, Powers R, Natarajan A, Hollingsworth MA, Mehla K, Ly Q, Chaudhary S, Hwang RF, Wellen KE, Singh PK. Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Nat Cell Biol. 2024 Apr; 26(4):613-627.

View in: PubMed
Malvi P, Chava S, Cai G, Hu K, Zhu LJ, Edwards YJK, Green MR, Gupta R, Wajapeyee N. HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway by regulating MSK1 and PPP2R2B. Cell Rep Med. 2023 11 21; 4(11):101285.

View in: PubMed
Chibaya L, Murphy KC, DeMarco KD, Gopalan S, Liu H, Parikh CN, Lopez-Diaz Y, Faulkner M, Li J, Morris JP, Ho YJ, Chana SK, Simon J, Luan W, Kulick A, de Stanchina E, Simin K, Zhu LJ, Fazzio TG, Lowe SW, Ruscetti M. EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance. Nat Cancer. 2023 06; 4(6):872-892.

View in: PubMed
Sayin S, Rosener B, Li CG, Ho B, Ponomarova O, Ward DV, Walhout AJM, Mitchell A. Evolved bacterial resistance to the chemotherapy gemcitabine modulates its efficacy in co-cultured cancer cells. Elife. 2023 02 03; 12.

View in: PubMed
Gupta R, Malvi P, Parajuli KR, Janostiak R, Bugide S, Cai G, Zhu LJ, Green MR, Wajapeyee N. KLF7 promotes pancreatic cancer growth and metastasis by up-regulating ISG expression and maintaining Golgi complex integrity. Proc Natl Acad Sci U S A. 2020 06 02; 117(22):12341-12351.

View in: PubMed
Sakhdari A, Moghaddam PA, Pejchal M, Cosar EF, Hutchinson L. Sequential molecular and cytologic analyses provides a complementary approach to the diagnosis of pancreatic cystic lesions: a decade of clinical practice. J Am Soc Cytopathol. 2020 Jan - Feb; 9(1):38-44.

View in: PubMed
Casta?eda-Avila M, Torres-Cintr?n CR, Cruz-Ben?tez A, Fuentes-Pay?n W, Maldonado-Albertorio A, Nieves-Ferrer L, Padr?-Juarbe P, Soto-Abreu R, Perez-R?os N, Ortiz-Ortiz KJ, Magno P, Ortiz AP. Pancreatic Cancer Incidence, Mortality, and Survival in Puerto Rico, 2001-2015. P R Health Sci J. 2019 09; 38(3):148-155.

View in: PubMed
Qayyum A, Tamm EP, Kamel IR, Allen PJ, Arif-Tiwari H, Chernyak V, Gonda TA, Grajo JR, Hindman NM, Horowitz JM, Kaur H, McNamara MM, Noto RB, Srivastava PK, Lalani T. ACR Appropriateness Criteria? Staging of Pancreatic Ductal Adenocarcinoma. J Am Coll Radiol. 2017 Nov; 14(11S):S560-S569.

View in: PubMed
Sakhdari A, Hutchinson L, Vaskas N, Scott M, Cosar EF, Al-Turkmani R. Routine Analysis of Lipase in Cyst Fluid Is Unnecessary and Does Not Help Discriminate Between Nonneoplastic and Neoplastic Cystic Pancreatic Lesions. Pancreas. 2017 Mar; 46(3):e25-e27.

View in: PubMed
Sano M, Driscoll DR, DeJesus-Monge WE, Quattrochi B, Appleman VA, Ou J, Zhu LJ, Yoshida N, Yamazaki S, Takayama T, Sugitani M, Nemoto N, Klimstra DS, Lewis BC. Activation of WNT/?-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61. Neoplasia. 2016 Dec; 18(12):785-794.

View in: PubMed

People

Explore

Similar Concepts

Top Journals